U.S. STOCKS ON THE MOVE-Boeing, Southwest Airlines, PDD Holdings
Vaxcyte rises on positive early-stage results for its pneumococcal vaccine
Vaxcyte Inc reports results for the quarter ended in June - Earnings Summary
Brief: Vaxcyte Q2 Operating Expenses USD 152.981 Million
Leerink views Lilly and Sarepta as defensive stocks in turbulent market
Vaxcyte Inc expected to post a loss of 98 cents a share - Earnings Preview
Brief: Vaxcyte Inc Files For Mixed Shelf Size Not Disclosed
Vaxcyte Inc reports results for the quarter ended in March - Earnings Summary
Brief: Vaxcyte Q1 Operating Expenses USD 114.472 Million
Vaxcyte Inc expected to post a loss of $1.17 a share - Earnings Preview
Brief: Vaxcyte Completes Phase 2 Study Enrollment Evaluating VAX-24 For Prevention Of Invasive Pneumococcal Disease in Infants
Vaxcyte Inc reports results for the quarter ended in December - Earnings Summary
Vaxcyte Inc expected to post a loss of $1.07 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Boeing, Mondelez International, Novavax
Vaxcyte gains after $750 mln equity raise
Brief: Vaxcyte Announces Pricing Of $750 Mln Public Offering
Brief: Vaxcyte Announces Commencement Of Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Vaxcyte Provides Clinical, Regulatory Progress Update On Pneumococcal Conjugate Vaccine Franchise
Brief: Vaxcyte Appoints Jacks Lee To Board Of Directors